PDC Biotech GmbH, a Vienna, Austria-based women’s health drug startup whose first product focuses on preterm labor and primary dysmenorrhea, has raised over €4M ($5.8M) in Series A funding. MIG Verwaltungs AG and Edmond de Rothschild Investment Partners co-led the round. Patricia Griffin and Diane Kalina are the co-founders of PDC, which was previously awarded €1M ($1.4M) in seed funding from the Austria Wirtschaftsservice (AWS) and a grant of €517K ($756K) from the Zentrum für Innovation und Technologie (ZIT, an agency of the City of Vienna for promotion of innovation and technology)...